www.inoviq.com Open in urlscan Pro
172.67.208.179  Public Scan

Form analysis
2 forms found in the DOM

Name: FormUserRegistration — POST /site/pub/UserRegistration.aspx

<form name="FormUserRegistration" method="post" action="/site/pub/UserRegistration.aspx" id="FormUserRegistration">
  <input type="hidden" name="gotoUrl" value="/site/contact/email-alerts/success">
  <!-- <p class='email-text'>To join Email Alerts, simply fill in your details using the form below and nominate which announcements you would like to receive.</p> -->
  <div class="email-form-mini">
    <div class="form-row"><input name="firstname" type="text" id="firstname" placeholder="First Name*" class="validate" required=""></div>
    <div class="form-row"><input name="lastname" type="text" id="lastname" placeholder="Last Name*" class="validate" required=""></div>
    <div class="form-row"><input name="email" type="email" id="email" placeholder="Email Address*" class="validate" required=""></div>
    <div class="form-row" style="display:none;">
      <input id="SubscriptionNewsSourceId_1" type="checkbox" name="SubscriptionNewsSourceId_1" class="styled-check" checked="">
      <label for="SubscriptionNewsSourceId_1">ASX Announcements</label>
    </div>
    <div class="form-row" style="display:none;">
      <input id="SubscriptionNewsSourceId_2" type="checkbox" name="SubscriptionNewsSourceId_2" class="styled-check" checked="">
      <label for="SubscriptionNewsSourceId_2">Media Releases &amp; News</label>
    </div>
    <div class="from-row" style="display:none;">
      <p>Which of the following group do you best fit?</p>
      <select name="UserType" id="UserType" required="">
        <option value="" disabled="" selected="">Which of the following group do you best fit?</option>
        <option value="Analyst">Analyst</option>
        <option value="Broker">Broker</option>
        <option value="Financial Adviser">Financial Adviser</option>
        <option value="Fund Manager">Fund Manager</option>
        <option value="Institutional Investor">Institutional Investor</option>
        <option value="Sophisticated Investor">Sophisticated Investor</option>
        <option value="Private Investor">Private Investor</option>
        <option value="Media Representative">Media Representative</option>
        <option value="General Interest" selected="">General Interest</option>
      </select>
    </div>
    <div class="form-row" style="display:none;">
      <label>
        <input id="ShareHolder_0" type="radio" name="ShareHolder" class="styled-radio" value="Yes"> <label for="ShareHolder_0">Yes</label>
        <input id="ShareHolder_1" type="radio" name="ShareHolder" class="styled-radio" value="No" checked=""> <label for="ShareHolder_1">No</label>
      </label>
    </div>
    <div class="form-row">
      <input type="submit" value="subscribe">
    </div>
  </div>
</form>

Name: aspnetForm — POST /site/content/

<form name="aspnetForm" method="post" action="/site/content/" id="aspnetForm">
  <div>
    <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE"
      value="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">
  </div>
  <div>
    <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="9691D5BE">
    <input type="hidden" name="__VIEWSTATEENCRYPTED" id="__VIEWSTATEENCRYPTED" value="">
  </div>
</form>

Text Content

 * About Us
   * About INOVIQ
   * Market Opportunity
   * Board
   * The Team
   * Partners
   * Distributors
   * Compliance
   * Careers
 * Technology
   * Our Science
   * NETs Platform
   * SubB2M Platform
   * BARD1 Biomarker Technology
   * hTERT ICC Assay
   * Intellectual Property
   * Publications
   * Resources
   * Business Development
 * Products
   * Our Products
   * EXO-NET® Pan-Exosome
     * Product Overview
     * Technical Information
     * Data & Figures
     * Ordering
   * hTERT ICC Test
 * Pipeline
   * Development Pipeline
   * SubB2M CA15-3
   * SubB2M CA125
   * Exo-Ovarian Cancer Test
   * Exosome Therapeutics
 * Investors
   * Investor Overview
   * ASX Announcements
   * Annual & Financial Reports
   * Presentations
   * Share Price Information
   * AGM
   * INOVIQ Fact Sheet
   * Corporate Governance
   * Shareholder Services
   * FAQ
   * Analyst Reports
 * News & Events
   * INOVIQ in the News
   * Conferences & Events
 * Contact
   * Contact Us
   * Subscribe to Email Alerts


Subscribe to Email Alerts
Menu
 * About Us
   * About INOVIQ
   * Market Opportunity
   * Board
   * The Team
   * Partners
   * Distributors
   * Compliance
   * Careers
 * Technology
   * Our Science
   * NETs Platform
   * SubB2M Platform
   * BARD1 Biomarker Technology
   * hTERT ICC Assay
   * Intellectual Property
   * Publications
   * Resources
   * Business Development
 * Products
   * Our Products
   * EXO-NET® Pan-Exosome
     * Product Overview
     * Technical Information
     * Data & Figures
     * Ordering
   * hTERT ICC Test
 * Pipeline
   * Development Pipeline
   * SubB2M CA15-3
   * SubB2M CA125
   * Exo-Ovarian Cancer Test
   * Exosome Therapeutics
 * Investors
   * Investor Overview
   * ASX Announcements
   * Annual & Financial Reports
   * Presentations
   * Share Price Information
   * AGM
   * INOVIQ Fact Sheet
   * Corporate Governance
   * Shareholder Services
   * FAQ
   * Analyst Reports
 * News & Events
   * INOVIQ in the News
   * Conferences & Events
 * Contact
   * Contact Us
   * Subscribe to Email Alerts

Previous


INNOVATIVE SOLUTIONS USING PROPRIETARY SUBB2M™, NETS, BARD1 AND HTERT
TECHNOLOGIES


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more


IMPROVING THE DIAGNOSIS
AND TREATMENT OF
CANCER AND OTHER DISEASES


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more


INOVIQ HAS A MULTI-PRODUCT PIPELINE FOR DETECTION AND MONITORING OF BREAST,
OVARIAN AND OTHER CANCERS


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more


INNOVATIVE SOLUTIONS USING PROPRIETARY SUBB2M™, NETS, BARD1 AND HTERT
TECHNOLOGIES


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more


IMPROVING THE DIAGNOSIS
AND TREATMENT OF
CANCER AND OTHER DISEASES


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more


INOVIQ HAS A MULTI-PRODUCT PIPELINE FOR DETECTION AND MONITORING OF BREAST,
OVARIAN AND OTHER CANCERS


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more


INNOVATIVE SOLUTIONS USING PROPRIETARY SUBB2M™, NETS, BARD1 AND HTERT
TECHNOLOGIES


SO YOUR ONLINE PRESENCE REALLY DELIVERS AT EACH STEP

Learn more
Next


WHO WE ARE

INOVIQ Ltd (ASX:IIQ) is developing and commercialising a portfolio of diagnostic
and exosome-based products for the earlier detection, diagnosis, prognosis and
monitoring of cancer and other diseases.

Learn More


WHO WE ARE

INOVIQ Ltd (ASX:IIQ) is developing and commercialising a portfolio of diagnostic
and exosome-based products for the earlier detection, diagnosis, prognosis and
monitoring of cancer and other diseases.




OUR TECHNOLOGIES

INOVIQ owns or licences the proprietary SubB2M™, NETs, BARD1 and hTERT
technologies that have multiple potential diagnostic and therapeutic
applications.

Read More


OUR PRODUCTS

INOVIQ has commercialised two products including the hTERT test for use as an
adjunct to urine cytology testing for bladder cancer and the EXO-NET®
pan-exosome capture tool for research purposes.

Read More


PIPELINE

INOVIQ is developing a multi-product diagnostic and exosome-based pipeline
focused on the detection and monitoring of cancer and other diseases to improve
patient health outcomes.



Read More


RECENT NEWS

17-Apr-2024
INOVIQ Investor Update
16-Apr-2024
INOVIQ Investor Webinar
15-Apr-2024
INOVIQ and Promega sign Global EXO-NET Agreement
12-Apr-2024
INOVIQ (ASX:IIQ) - Webinar Presentation
Read More >


LATEST PRESENTATION

12-Apr-2024
ShareCafe Presentation - Hidden Gems Webinar
Investor Presentations >


SHARE PRICE

ASX: $0.63
Nov
Dec
'24
Feb
Mar
Apr
Nov
Dec
'24
Feb
Mar
Apr
Nov
Dec
'24
Feb
Mar
Apr
Nov
Dec
'24
Feb
Mar
Apr
$0.50
$0.60
$0.70
$0.80
$0.90
$0.50
$0.60
$0.70
$0.80
$0.90
$0.50
$0.60
$0.70
$0.80
$0.90
$0.50
$0.60
$0.70
$0.80
$0.90


Read More >
Subscribe To
Email Alerts
ASX Announcements
Media Releases & News

Which of the following group do you best fit?

Which of the following group do you best fit? Analyst Broker Financial Adviser
Fund Manager Institutional Investor Sophisticated Investor Private Investor
Media Representative General Interest
Yes No




QUICK LINKS

About UsTechnologyProductsPipelineInvestorsNews & EventsContact


CONTACT US

Melbourne:
T: +61 3 9548 7586
23 Normanby Road
Notting Hill VIC 3168
Australia

US Office:
987 Old Eagle School Road, Suite 709
Wayne, PA 19087

Online:
E: info@inoviq.com
W: www.inoviq.com


EMAIL ALERTS

Subscribe to Email Alerts


FOLLOW US


Copyright © 2024 INOVIQ
Site Map Privacy Search
Site by